 | • レポートコード：360iR22NM005 • 出版社/出版日：360iResearch / 2022年10月 • レポート形態：英語、PDF、240ページ • 納品方法：Eメール（受注後2-3日） • 産業分類：バイオ |
| Single User（1名利用、印刷可） | ￥732,452 (USD4,949) | ▷ お問い合わせ |
| Enterprise License（企業利用、印刷可） | ￥1,472,452 (USD9,949) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 360iResearch社の本リサーチレポートによると、2021年に3,950.3億ドルであった世界のバイオテクノロジー試薬・キット市場規模が、2022年に4,636.4億ドルになり、2027年まで年平均17.54%で成長して10,420.8億ドルに達する見通しです。本レポートでは、バイオテクノロジー試薬・キットの世界市場について調査し、序論、調査方法、エグゼクティブサマリー、市場概要、市場インサイト、種類別（増幅キット、検出キット、単離キット、精製キット）分析、技術別（細胞培養、クロマトグラフィー、電気泳動、フローサイトメトリー、PCR）分析、検査パラメータ別（DNA、酵素、タンパク質、RNA）分析、エンドユーザー別（食品・農業、医療、産業加工、天然資源・環境）分析、地域別（南北アメリカ、アメリカ、カナダ、ブラジル、アジア太平洋、日本、中国、インド、韓国、台湾、ヨーロッパ/中東/アフリカ、イギリス、ドイツ、フランス、ロシア、その他）分析、競争状況、企業情報などを整理しています。本書に記載されている企業情報としては、Abbott Laboratories、Agilent Technologies, Inc.、Beckman Coulter Inc.、Becton, Dickinson and Company（BD）、Bio-Rad Laboratories, Inc.、Biomerieux、F. Hoffmann-La Roche Ltd.、GE Healthcare、Hoefer Inc.、Illumina, Inc.などが含まれています。 ・序論 ・調査方法 ・エグゼクティブサマリー ・市場概要 ・市場インサイト ・世界のバイオテクノロジー試薬・キット市場規模：種類別 - 増幅キットの市場規模 - 検出キットの市場規模 - 単離キットの市場規模 - 精製キットの市場規模 ・世界のバイオテクノロジー試薬・キット市場規模：技術別 - 細胞培養用試薬・キットの市場規模 - クロマトグラフィー用試薬・キットの市場規模 - 電気泳動用試薬・キットの市場規模 - フローサイトメトリー用試薬・キットの市場規模 - PCR用試薬・キットの市場規模 ・世界のバイオテクノロジー試薬・キット市場規模：検査パラメータ別 - DNA検査用試薬・キットの市場規模 - 酵素検査用試薬・キットの市場規模 - タンパク質検査用試薬・キットの市場規模 - RNA検査用試薬・キットの市場規模 ・世界のバイオテクノロジー試薬・キット市場規模：エンドユーザー別 - 食品・農業における市場規模 - 医療における市場規模 - 産業加工における市場規模 - 天然資源・環境における市場規模 ・世界のバイオテクノロジー試薬・キット市場規模：地域別 - 南北アメリカのバイオテクノロジー試薬・キット市場規模 アメリカのバイオテクノロジー試薬・キット市場規模 カナダのバイオテクノロジー試薬・キット市場規模 ブラジルのバイオテクノロジー試薬・キット市場規模 … - アジア太平洋のバイオテクノロジー試薬・キット市場規模 日本のバイオテクノロジー試薬・キット市場規模 中国のバイオテクノロジー試薬・キット市場規模 インドのバイオテクノロジー試薬・キット市場規模 韓国のバイオテクノロジー試薬・キット市場規模 台湾のバイオテクノロジー試薬・キット市場規模 … - ヨーロッパ/中東/アフリカのバイオテクノロジー試薬・キット市場規模 イギリスのバイオテクノロジー試薬・キット市場規模 ドイツのバイオテクノロジー試薬・キット市場規模 フランスのバイオテクノロジー試薬・キット市場規模 ロシアのバイオテクノロジー試薬・キット市場規模 … - その他地域のバイオテクノロジー試薬・キット市場規模 ・競争状況 ・企業情報 |
The Global Biotechnology Reagents & Kits Market size was estimated at USD 395.03 billion in 2021 and expected to reach USD 463.64 billion in 2022, and is projected to grow at a CAGR 17.54% to reach USD 1,042.08 billion by 2027.
Market Statistics:
The report provides market sizing and forecast across 7 major currencies – USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.
Market Segmentation & Coverage:
This research report categorizes the Biotechnology Reagents & Kits to forecast the revenues and analyze the trends in each of the following sub-markets:
Based on Type, the market was studied across Amplification Kits, Detection Kits, Isolation Kits, and Purification Kits.
Based on Micro-Organisms, the market was studied across Bacteria, Fungi, Parasites, and Virus.
Based on Technology, the market was studied across Cell Culture, Chromatography, Electrophoresis, Flow Cytometry, LAMP Technology, PCR, and Sequencing.
Based on Tested Parameters, the market was studied across DNA, Enzymes, Proteins, and RNA.
Based on Purpose, the market was studied across Laboratory and On-Site.
Based on End-use, the market was studied across Food & Agriculture, Healthcare, Industrial Processing, and Natural Resources & Environment.
Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.
Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.
Cumulative Impact of 2022 Russia Ukraine Conflict:
We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Biotechnology Reagents & Kits market considering the current update on the conflict and its global response.
Competitive Strategic Window:
The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.
FPNV Positioning Matrix:
The FPNV Positioning Matrix evaluates and categorizes the vendors in the Biotechnology Reagents & Kits Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.
Market Share Analysis:
The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.
Competitive Scenario:
The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.
Company Usability Profiles:
The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Biotechnology Reagents & Kits Market, including Abbott Laboratories, Agilent Technologies, Inc., Beckman Coulter Inc., Becton, Dickinson and Company (BD), Bio-Rad Laboratories, Inc., Biomerieux, F. Hoffmann-La Roche Ltd., GE Healthcare, Hoefer Inc., Illumina, Inc., LGC Limited, Life Technologies Corporation, Lonza Group Ltd., Merck KGaA, New England Biolabs, Promega Corporation, Qiagen, Takara Bio, Inc., Thermo Fisher Scientific, Inc., and Toyobo Co. Ltd..
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments
The report answers questions such as:
1. What is the market size and forecast of the Global Biotechnology Reagents & Kits Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Biotechnology Reagents & Kits Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Biotechnology Reagents & Kits Market?
4. What is the competitive strategic window for opportunities in the Global Biotechnology Reagents & Kits Market?
5. What are the technology trends and regulatory frameworks in the Global Biotechnology Reagents & Kits Market?
6. What is the market share of the leading vendors in the Global Biotechnology Reagents & Kits Market?
7. What modes and strategic moves are considered suitable for entering the Global Biotechnology Reagents & Kits Market?
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increase in protein profiling application
5.1.1.2. Evolving landscape for the biotechnology landscape
5.1.1.3. Growing burden of cancer, genetic disorders and chronic infectious disease
5.1.2. Restraints
5.1.2.1. Contamination issue
5.1.2.2. Stringent government regulations for approval of reagents
5.1.3. Opportunities
5.1.3.1. Huge investment by corporate and research organization
5.1.3.2. High R&D expenditure by biotechnology companies coupled with rise in number of biotechnology firms
5.1.4. Challenges
5.1.4.1. High cost of reagents and kits
5.2. Cumulative Impact of COVID-19
6. Biotechnology Reagents & Kits Market, by Type
6.1. Introduction
6.2. Amplification Kits
6.3. Detection Kits
6.4. Isolation Kits
6.5. Purification Kits
7. Biotechnology Reagents & Kits Market, by Micro-Organisms
7.1. Introduction
7.2. Bacteria
7.3. Fungi
7.4. Parasites
7.5. Virus
8. Biotechnology Reagents & Kits Market, by Technology
8.1. Introduction
8.2. Cell Culture
8.3. Chromatography
8.4. Electrophoresis
8.5. Flow Cytometry
8.6. LAMP Technology
8.7. PCR
8.8. Sequencing
9. Biotechnology Reagents & Kits Market, by Tested Parameters
9.1. Introduction
9.2. DNA
9.3. Enzymes
9.4. Proteins
9.5. RNA
10. Biotechnology Reagents & Kits Market, by Purpose
10.1. Introduction
10.2. Laboratory
10.3. On-Site
11. Biotechnology Reagents & Kits Market, by End-use
11.1. Introduction
11.2. Food & Agriculture
11.3. Healthcare
11.4. Industrial Processing
11.5. Natural Resources & Environment
12. Americas Biotechnology Reagents & Kits Market
12.1. Introduction
12.2. Argentina
12.3. Brazil
12.4. Canada
12.5. Mexico
12.6. United States
13. Asia-Pacific Biotechnology Reagents & Kits Market
13.1. Introduction
13.2. Australia
13.3. China
13.4. India
13.5. Indonesia
13.6. Japan
13.7. Malaysia
13.8. Philippines
13.9. Singapore
13.10. South Korea
13.11. Taiwan
13.12. Thailand
13.13. Vietnam
14. Europe, Middle East & Africa Biotechnology Reagents & Kits Market
14.1. Introduction
14.2. Denmark
14.3. Egypt
14.4. Finland
14.5. France
14.6. Germany
14.7. Israel
14.8. Italy
14.9. Netherlands
14.10. Nigeria
14.11. Norway
14.12. Poland
14.13. Qatar
14.14. Russia
14.15. Saudi Arabia
14.16. South Africa
14.17. Spain
14.18. Sweden
14.19. Switzerland
14.20. Turkey
14.21. United Arab Emirates
14.22. United Kingdom
15. Competitive Landscape
15.1. FPNV Positioning Matrix
15.1.1. Quadrants
15.1.2. Business Strategy
15.1.3. Product Satisfaction
15.2. Market Ranking Analysis, By Key Player
15.3. Market Share Analysis, By Key Player
15.4. Competitive Scenario
15.4.1. Merger & Acquisition
15.4.2. Agreement, Collaboration, & Partnership
15.4.3. New Product Launch & Enhancement
15.4.4. Investment & Funding
15.4.5. Award, Recognition, & Expansion
16. Company Usability Profiles
16.1. Abbott Laboratories
16.1.1. Business Overview
16.1.2. Key Executives
16.1.3. Product & Services
16.2. Agilent Technologies, Inc.
16.2.1. Business Overview
16.2.2. Key Executives
16.2.3. Product & Services
16.3. Beckman Coulter Inc.
16.3.1. Business Overview
16.3.2. Key Executives
16.3.3. Product & Services
16.4. Becton, Dickinson and Company (BD)
16.4.1. Business Overview
16.4.2. Key Executives
16.4.3. Product & Services
16.5. Bio-Rad Laboratories, Inc.
16.5.1. Business Overview
16.5.2. Key Executives
16.5.3. Product & Services
16.6. Biomerieux
16.6.1. Business Overview
16.6.2. Key Executives
16.6.3. Product & Services
16.7. F. Hoffmann-La Roche Ltd.
16.7.1. Business Overview
16.7.2. Key Executives
16.7.3. Product & Services
16.8. GE Healthcare
16.8.1. Business Overview
16.8.2. Key Executives
16.8.3. Product & Services
16.9. Hoefer Inc.
16.9.1. Business Overview
16.9.2. Key Executives
16.9.3. Product & Services
16.10. Illumina, Inc.
16.10.1. Business Overview
16.10.2. Key Executives
16.10.3. Product & Services
16.11. LGC Limited
16.11.1. Business Overview
16.11.2. Key Executives
16.11.3. Product & Services
16.12. Life Technologies Corporation
16.12.1. Business Overview
16.12.2. Key Executives
16.12.3. Product & Services
16.13. Lonza Group Ltd.
16.13.1. Business Overview
16.13.2. Key Executives
16.13.3. Product & Services
16.14. Merck KGaA
16.14.1. Business Overview
16.14.2. Key Executives
16.14.3. Product & Services
16.15. New England Biolabs
16.15.1. Business Overview
16.15.2. Key Executives
16.15.3. Product & Services
16.16. Promega Corporation
16.16.1. Business Overview
16.16.2. Key Executives
16.16.3. Product & Services
16.17. Qiagen
16.17.1. Business Overview
16.17.2. Key Executives
16.17.3. Product & Services
16.18. Takara Bio, Inc.
16.18.1. Business Overview
16.18.2. Key Executives
16.18.3. Product & Services
16.19. Thermo Fisher Scientific, Inc.
16.19.1. Business Overview
16.19.2. Key Executives
16.19.3. Product & Services
16.20. Toyobo Co. Ltd.
16.20.1. Business Overview
16.20.2. Key Executives
16.20.3. Product & Services
17. Appendix
17.1. Discussion Guide
17.2. License & Pricing